Expression and Characterization of GSK-3 Mutants and Their Effect on β-Catenin Phosphorylation in Intact Cells
Open Access
- 1 June 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (26), 23330-23335
- https://doi.org/10.1074/jbc.m201364200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activityFEBS Letters, 2001
- Differential Molecular Assemblies Underlie the Dual Function of Axin in Modulating the Wnt and JNK PathwaysJournal of Biological Chemistry, 2001
- Control of β-Catenin StabilityMolecular Cell, 2000
- A GSK3β Phosphorylation Site in Axin Modulates Interaction with β-Catenin and Tcf-Mediated Gene ExpressionBiochemical and Biophysical Research Communications, 1999
- A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐cateninFEBS Letters, 1999
- Transient Increases in Intracellular Calcium Result in Prolonged Site-selective Increases in Tau Phosphorylation through a Glycogen Synthase Kinase 3β-dependent PathwayJournal of Biological Chemistry, 1999
- The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitroGenes & Development, 1999
- Stabilization of β-Catenin by Genetic Defects in Melanoma Cell LinesScience, 1997
- Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex AssemblyScience, 1996
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995